Table of Contents Global Overactive Bladder Therapeutics Sales Market Report 2018 by Manufacturer, Region, Type and Application 1 Overactive Bladder Therapeutics Market Overview 1.1 Product Overview and Scope of Overactive Bladder Therapeutics 1.2 Classification of Overactive Bladder Therapeutics by Product Category 1.2.1 Global Overactive Bladder Therapeutics Market Size (Sales) Comparison by Type (2012-2023) 1.2.2 Global Overactive Bladder Therapeutics Market Size (Sales) Market Share by Type (Product Category) in 2017 1.2.3 Anti-Muscarinic Agent 1.2.4 Beta-3-Adrenergic Receptor Agonist 1.2.5 Others 1.3 Global Overactive Bladder Therapeutics Market by Application/End Users 1.3.1 Global Overactive Bladder Therapeutics Sales (Volume) and Market Share Comparison by Application (2012-2023) 1.3.2 Medical Care 1.3.3 Medical Research 1.3.4 Others 1.4 Global Overactive Bladder Therapeutics Market by Region 1.4.1 Global Overactive Bladder Therapeutics Market Size (Value) Comparison by Region (2012-2023) 1.4.2 North America Overactive Bladder Therapeutics Status and Prospect (2012-2023) 1.4.3 Europe Overactive Bladder Therapeutics Status and Prospect (2012-2023) 1.4.4 China Overactive Bladder Therapeutics Status and Prospect (2012-2023) 1.4.5 Japan Overactive Bladder Therapeutics Status and Prospect (2012-2023) 1.4.6 Southeast Asia Overactive Bladder Therapeutics Status and Prospect (2012-2023) 1.4.7 India Overactive Bladder Therapeutics Status and Prospect (2012-2023) 1.5 Global Market Size (Value and Volume) of Overactive Bladder Therapeutics (2012-2023) 1.5.1 Global Overactive Bladder Therapeutics Sales and Growth Rate (2012-2023) 1.5.2 Global Overactive Bladder Therapeutics Revenue and Growth Rate (2012-2023) 2 Industrial Chain Analysis 2.1 Industry Chain Structure of Overactive Bladder Therapeutics 2.2 Raw Material Analysis of Overactive Bladder Therapeutics 2.1.1 Raw Material A Market Analysis 2.1.2 Raw Material B Market Analysis 2.1.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of Overactive Bladder Therapeutics 2.4 Other Costs Analysis of Overactive Bladder Therapeutics 2.5 Manufacturing Cost Structure Analysis of Overactive Bladder Therapeutics 2.6 Manufacturing Process Analysis of Overactive Bladder Therapeutics 2.7 Raw Materials Sources of Overactive Bladder Therapeutics Major Manufacturers in 2017 2.8 Downstream Buyers 3 Global Overactive Bladder Therapeutics Players/Suppliers Profiles and Sales Data 3.1 Actavis 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.1.2.1 Product A 3.1.2.2 Product B 3.1.3 Actavis Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.4 Actavis Different Types of Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.5 Actavis Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.2 Allergan 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.2.2.1 Product A 3.2.2.2 Product B 3.2.3 Allergan Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.4 Allergan Different Types of Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.5 Allergan Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.3 Astellas Pharma 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.3.2.1 Product A 3.3.2.2 Product B 3.3.3 Astellas Pharma Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.4 Astellas Pharma Different Types of Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.5 Astellas Pharma Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.4 Pfizer 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.4.2.1 Product A 3.4.2.2 Product B 3.4.3 Pfizer Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.4 Pfizer Different Types of Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.5 Pfizer Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.5 Addex Pharmaceuticals Ltd 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.5.2.1 Product A 3.5.2.2 Product B 3.5.3 Addex Pharmaceuticals Ltd Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.4 Addex Pharmaceuticals Ltd Different Types of Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.5 Addex Pharmaceuticals Ltd Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.6 Bayer 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.6.2.1 Product A 3.6.2.2 Product B 3.6.3 Bayer Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.4 Bayer Different Types of Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.5 Bayer Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.7 Elbion 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.7.2.1 Product A 3.7.2.2 Product B 3.7.3 Elbion Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.4 Elbion Different Types of Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.5 Elbion Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.8 Ipsen 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.8.2.1 Product A 3.8.2.2 Product B 3.8.3 Ipsen Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.4 Ipsen Different Types of Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.5 Ipsen Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.9 Janssen 3.9.1 Company Basic Information, Manufacturing Base and Competitors 3.9.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.9.2.1 Product A 3.9.2.2 Product B 3.9.3 Janssen Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.9.4 Janssen Different Types of Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.9.5 Janssen Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.10 Kissei Pharma 3.10.1 Company Basic Information, Manufacturing Base and Competitors 3.10.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.10.2.1 Product A 3.10.2.2 Product B 3.10.3 Kissei Pharma Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.10.4 Kissei Pharma Different Types of Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.10.5 Kissei Pharma Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 4 Global Overactive Bladder Therapeutics Market Competition by Players 4.1 Global Overactive Bladder Therapeutics Sales (K Units) and Market Share (%) of Key Players (2012-2017) 4.1.1 Global Overactive Bladder Therapeutics Sales (K Units) and Market Share (%) of Key Players (2012-2017) 4.1.2 Global Overactive Bladder Therapeutics Revenue (Million USD) and Share by Players (2012-2017) 4.2 Global Overactive Bladder Therapeutics Sales and Revenue by Type 4.1.1 Global Overactive Bladder Therapeutics Sales (K Units) and Market Share (%) by Type (2012-2017) 4.1.2 Global Overactive Bladder Therapeutics Revenue (Million USD) and Market Share (%) by Type (2012-2017) 4.3 Global Overactive Bladder Therapeutics Sales and Revenue by Regions 4.3.1 Global Overactive Bladder Therapeutics Sales (K Units) and Market Share (%) by Regions (2012-2017) 4.3.2 Global Overactive Bladder Therapeutics Revenue and Market Share (%) by Regions (2012-2017) 4.4 Global Overactive Bladder Therapeutics Revenue and Market Share (%) by Regions (2012-2017) 5 North America Overactive Bladder Therapeutics (Volume, Value and Sales Price) 5.1 North America Overactive Bladder Therapeutics Sales and Value (2012-2017) 5.1.1 North America Overactive Bladder Therapeutics Sales and Growth Rate (2012-2017) 5.1.2 North America Overactive Bladder Therapeutics Revenue and Growth Rate (2012-2017) 5.1.3 North America Overactive Bladder Therapeutics Sales Price Trend (2012-2017) 5.2 North America Overactive Bladder Therapeutics Sales Volume and Market Share by Players 5.3 North America Overactive Bladder Therapeutics Sales Volume and Market Share by Type 5.4 North America Overactive Bladder Therapeutics Sales Volume and Market Share by Application 6 Europe Overactive Bladder Therapeutics (Volume, Value and Sales Price) 6.1 Europe Overactive Bladder Therapeutics Sales and Value (2012-2017) 6.1.1 Europe Overactive Bladder Therapeutics Sales and Growth Rate (2012-2017) 6.1.2 Europe Overactive Bladder Therapeutics Revenue and Growth Rate (2012-2017) 6.1.3 Europe Overactive Bladder Therapeutics Sales Price Trend (2012-2017) 6.2 Europe Overactive Bladder Therapeutics Sales Volume and Market Share by Players 6.3 Europe Overactive Bladder Therapeutics Sales Volume and Market Share by Type 6.4 Europe Overactive Bladder Therapeutics Sales Volume and Market Share by Application 7 China Overactive Bladder Therapeutics (Volume, Value and Sales Price) 7.1 China Overactive Bladder Therapeutics Sales and Value (2012-2017) 7.1.1 China Overactive Bladder Therapeutics Sales and Growth Rate (2012-2017) 7.1.2 China Overactive Bladder Therapeutics Revenue and Growth Rate (2012-2017) 7.1.3 China Overactive Bladder Therapeutics Sales Price Trend (2012-2017) 7.2 China Overactive Bladder Therapeutics Sales Volume and Market Share by Players 7.3 China Overactive Bladder Therapeutics Sales Volume and Market Share by Type 7.4 China Overactive Bladder Therapeutics Sales Volume and Market Share by Application 8 Japan Overactive Bladder Therapeutics (Volume, Value and Sales Price) 8.1 Japan Overactive Bladder Therapeutics Sales and Value (2012-2017) 8.1.1 Japan Overactive Bladder Therapeutics Sales and Growth Rate (2012-2017) 8.1.2 Japan Overactive Bladder Therapeutics Revenue and Growth Rate (2012-2017) 8.1.3 Japan Overactive Bladder Therapeutics Sales Price Trend (2012-2017) 8.2 Japan Overactive Bladder Therapeutics Sales Volume and Market Share by Players 8.3 Japan Overactive Bladder Therapeutics Sales Volume and Market Share by Type 8.4 Japan Overactive Bladder Therapeutics Sales Volume and Market Share by Application 9 Southeast Asia Overactive Bladder Therapeutics (Volume, Value and Sales Price) 9.1 Southeast Asia Overactive Bladder Therapeutics Sales and Value (2012-2017) 9.1.1 Southeast Asia Overactive Bladder Therapeutics Sales and Growth Rate (2012-2017) 9.1.2 Southeast Asia Overactive Bladder Therapeutics Revenue and Growth Rate (2012-2017) 9.1.3 Southeast Asia Overactive Bladder Therapeutics Sales Price Trend (2012-2017) 9.2 Southeast Asia Overactive Bladder Therapeutics Sales Volume and Market Share by Players 9.3 Southeast Asia Overactive Bladder Therapeutics Sales Volume and Market Share by Type 9.4 Southeast Asia Overactive Bladder Therapeutics Sales Volume and Market Share by Application 10 India Overactive Bladder Therapeutics (Volume, Value and Sales Price) 10.1 India Overactive Bladder Therapeutics Sales and Value (2012-2017) 10.1.1 India Overactive Bladder Therapeutics Sales and Growth Rate (2012-2017) 10.1.2 India Overactive Bladder Therapeutics Revenue and Growth Rate (2012-2017) 10.1.3 India Overactive Bladder Therapeutics Sales Price Trend (2012-2017) 10.2 India Overactive Bladder Therapeutics Sales Volume and Market Share by Players 10.3 India Overactive Bladder Therapeutics Sales Volume and Market Share by Type 10.4 India Overactive Bladder Therapeutics Sales Volume and Market Share by Application 11 Marketing Strategy Analysis, Distributors/Traders 11.1 Direct Marketing 11.1.1 Direct Marketing 11.1.2 Indirect Marketing 11.1.3 Marketing Channel Development Trend 11.2 Market Positioning 11.2.1 Pricing Strategy 11.2.2 Brand Strategy 11.2.3 Target Client 11.3 Distributors/Traders List 12 Global Overactive Bladder Therapeutics Market Forecast (2018-2023) 12.1 Global Overactive Bladder Therapeutics Sales Volume, Revenue and Price Forecast (2018-2023) 12.1.1 Global Overactive Bladder Therapeutics Sales Volume and Growth Rate Forecast (2018-2023) 12.1.2 Global Overactive Bladder Therapeutics Revenue and Growth Rate Forecast (2018-2023) 12.1.3 Global Overactive Bladder Therapeutics Price and Trend Forecast (2018-2023) 12.2 Global Overactive Bladder Therapeutics Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2023) 12.2.1 Global Overactive Bladder Therapeutics Sales Volume and Growth Rate Forecast by Regions (2018-2023) 12.2.2 Global Overactive Bladder Therapeutics Revenue and Growth Rate Forecast by Regions (2018-2023) 12.2.3 North America Overactive Bladder Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 12.2.4 Europe Overactive Bladder Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 12.2.5 China Overactive Bladder Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 12.2.6 Japan Overactive Bladder Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 12.2.7 Southeast Asia Overactive Bladder Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 12.2.8 India Overactive Bladder Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 12.3 Global Overactive Bladder Therapeutics Sales Volume, Revenue and Price Forecast by Type (2018-2023) 12.3.1 Global Overactive Bladder Therapeutics Sales Forecast by Type (2018-2023) 12.3.2 Global Overactive Bladder Therapeutics Revenue Forecast by Type (2018-2023) 12.3.3 Global Overactive Bladder Therapeutics Price Forecast by Type (2018-2023) 12.4 Global Overactive Bladder Therapeutics Sales Volume Forecast by Application (2018-2023) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology/Research Approach 14.1.1 Research Programs/Design 14.1.2 Market Size Estimation 14.1.3 Market Breakdown and Data Triangulation 14.2 Data Source 14.2.1 Secondary Sources 14.2.2 Primary Sources 14.3 Disclaimer

List of Tables and Figures Figure Global Market Size (Million USD) Status and Outlook 2012-2023 Table Global Market Overactive Bladder Therapeutics Revenue (Million USD) Comparison by Regions 2012-2023 Table Overactive Bladder Therapeutics Sales (K Units) and Revenue (Million USD) Market Split by Product Type Table Overactive Bladder Therapeutics Sales (K Units) by Application (2016-2023) Figure Product Picture of Overactive Bladder Therapeutics Table Global Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (%) Comparison by Types (2012-2023) Figure Global Overactive Bladder Therapeutics Sales Market Share (%) by Types in 2017 Figure Anti-Muscarinic Agent Picture Figure Beta-3-Adrenergic Receptor Agonist Picture Figure Others Picture Table Global Overactive Bladder Therapeutics Sales (K Units) Comparison by Applications (2012-2023) Figure Global Sales Market Share (%) of Overactive Bladder Therapeutics by Applications in 2017 Figure Medical Care Picture Figure Medical Research Picture Figure Others Picture Table Global Market Overactive Bladder Therapeutics Revenue (Million USD) Comparison by Regions 2012-2023 Figure North America Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure China Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure Europe Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure Japan Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure Southeast Asia Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure India Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure Global Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (2012-2023) Figure Global Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Table Global Overactive Bladder Therapeutics Sales (K Units) of Key Players (2012-2017) Table Global Overactive Bladder Therapeutics Sales Share (%) by Players (2012-2017) Figure 2016 Global Overactive Bladder Therapeutics Sales Share (%) by Players Figure 2017 Global Overactive Bladder Therapeutics Sales Share (%) by Players Table Global Overactive Bladder Therapeutics Revenue by Players (2012-2017) Table Global Overactive Bladder Therapeutics Revenue Share (%) by Players (2012-2017) Figure 2016 Global Overactive Bladder Therapeutics Revenue Share (%) by Players Figure 2017 Global Overactive Bladder Therapeutics Revenue Share (%) by Players Table Global Overactive Bladder Therapeutics Sales (K Units) by Type (2012-2017) Table Global Overactive Bladder Therapeutics Sales Share (%) by Type (2012-2017) Figure Sales Market Share (%) of Overactive Bladder Therapeutics by Type (2012-2017) Figure Global Overactive Bladder Therapeutics Sales Growth Rate by Type (2012-2017) Table Global Overactive Bladder Therapeutics Revenue (Million USD) and Market Share (%) by Type (2012-2017) Table Global Overactive Bladder Therapeutics Revenue Share (%) by Type (2012-2017) Figure Revenue Market Share (%) of Overactive Bladder Therapeutics by Type (2012-2017) Figure Global Overactive Bladder Therapeutics Revenue Growth Rate by Type (2012-2017) Table Global Overactive Bladder Therapeutics Sales (K Units) and Market Share (%) by Regions (2012-2017) Table Global Overactive Bladder Therapeutics Sales Share (%) by Regions (2012-2017) Figure Sales Market Share (%) of Overactive Bladder Therapeutics by Regions (2012-2017) Figure Global Overactive Bladder Therapeutics Sales Market Share (%) by Regions in 2017 Table Global Overactive Bladder Therapeutics Revenue (Million USD) and Market Share (%) by Regions (2012-2017) Table Global Overactive Bladder Therapeutics Revenue Share (%) by Regions (2012-2017) Figure Revenue Market Share (%) of Overactive Bladder Therapeutics by Regions (2012-2017) Figure Global Overactive Bladder Therapeutics Revenue Market Share (%) by Regions in 2017 Table Global Overactive Bladder Therapeutics Sales (K Units) and Market Share (%) by Application (2012-2017) Table Global Overactive Bladder Therapeutics Sales Share (%) by Application (2012-2017) Figure Sales Market Share (%) of Overactive Bladder Therapeutics by Application (2012-2017) Figure Global Overactive Bladder Therapeutics Sales Market Share (%) by Application (2012-2017) Figure North America Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (%) (2012-2017) Figure North America Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (2012-2017) Figure North America Overactive Bladder Therapeutics Price (USD/Unit) Trend (2012-2017) Table North America Overactive Bladder Therapeutics Sales (K Units) by Players (2012-2017) Table North America Overactive Bladder Therapeutics Sales (K Units) Market Share (%) by Players (2012-2017) Figure North America Overactive Bladder Therapeutics Sales (K Units) Market Share (%) by Players in 2017 Table North America Overactive Bladder Therapeutics Sales (K Units) by Type (2012-2017) Table North America Overactive Bladder Therapeutics Sales (K Units) Market Share (%) by Type (2012-2017) Figure North America Overactive Bladder Therapeutics Sales (K Units) Market Share (%) by Type in 2017 Table North America Overactive Bladder Therapeutics Sales (K Units) by Applications (2012-2017) Table North America Overactive Bladder Therapeutics Sales (K Units) Market Share (%) by Applications (2012-2017) Figure North America Overactive Bladder Therapeutics Sales (K Units) Market Share (%) by Applications in 2017 Figure China Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (2012-2017) Figure China Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (2012-2017) Figure China Overactive Bladder Therapeutics Price (USD/Unit) Trend (2012-2017) Table China Overactive Bladder Therapeutics Sales (K Units) by Players (2012-2017) Table China Overactive Bladder Therapeutics Sales (K Units) Market Share (%) by Players (2012-2017) Figure China Overactive Bladder Therapeutics Sales (K Units) Market Share (%) by Players in 2017 Table China Overactive Bladder Therapeutics Sales (K Units) by Type (2012-2017) Table China Overactive Bladder Therapeutics Sales (K Units) Market Share (%) by Type (2012-2017) Figure China Overactive Bladder Therapeutics Sales (K Units) Market Share (%) by Type in 2017 Table China Overactive Bladder Therapeutics Sales (K Units) by Applications (2012-2017) Table China Overactive Bladder Therapeutics Sales (K Units) Market Share (%) by Applications (2012-2017) Figure China Overactive Bladder Therapeutics Sales (K Units) Market Share (%) by Applications in 2017 Figure Europe Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (2012-2017) Figure Europe Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (2012-2017) Figure Europe Overactive Bladder Therapeutics Price (USD/Unit) Trend (2012-2017) Table Europe Overactive Bladder Therapeutics Sales (K Units) by Players (2012-2017) Table Europe Overactive Bladder Therapeutics Sales (K Units) Market Share (%) by Players (2012-2017) Figure Europe Overactive Bladder Therapeutics Sales (K Units) Market Share (%) by Players in 2017 Table Europe Overactive Bladder Therapeutics Sales (K Units) by Type (2012-2017) Table Europe Overactive Bladder Therapeutics Sales (K Units) Market Share (%) by Type (2012-2017) Figure Europe Overactive Bladder Therapeutics Sales (K Units) Market Share (%) by Type in 2017 Table Europe Overactive Bladder Therapeutics Sales (K Units) by Applications (2012-2017) Table Europe Overactive Bladder Therapeutics Sales (K Units) Market Share (%) by Applications (2012-2017) Figure Europe Overactive Bladder Therapeutics Sales (K Units) Market Share (%) by Applications in 2017 Figure Japan Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (2012-2017) Figure Japan Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (2012-2017) Figure Japan Overactive Bladder Therapeutics Price (USD/Unit) Trend (2012-2017) Table Japan Overactive Bladder Therapeutics Sales (K Units) by Players (2012-2017) Table Japan Overactive Bladder Therapeutics Sales (K Units) Market Share (%) by Players (2012-2017) Figure Japan Overactive Bladder Therapeutics Sales (K Units) Market Share (%) by Players in 2017 Table Japan Overactive Bladder Therapeutics Sales (K Units) by Type (2012-2017) Table Japan Overactive Bladder Therapeutics Sales (K Units) Market Share (%) by Type (2012-2017) Figure Japan Overactive Bladder Therapeutics Sales (K Units) Market Share (%) by Type in 2017 Table Japan Overactive Bladder Therapeutics Sales (K Units) by Applications (2012-2017) Table Japan Overactive Bladder Therapeutics Sales (K Units) Market Share (%) by Applications (2012-2017) Figure Japan Overactive Bladder Therapeutics Sales (K Units) Market Share (%) by Applications in 2017 Figure India Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (2012-2017) Figure India Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (2012-2017) Figure India Overactive Bladder Therapeutics Price (USD/Unit) Trend (2012-2017) Table India Overactive Bladder Therapeutics Sales (K Units) by Players (2012-2017) Table India Overactive Bladder Therapeutics Sales (K Units) Market Share (%) by Players (2012-2017) Figure India Overactive Bladder Therapeutics Sales (K Units) Market Share (%) by Players in 2017 Table India Overactive Bladder Therapeutics Sales (K Units) by Type (2012-2017) Table India Overactive Bladder Therapeutics Sales (K Units) Market Share (%) by Type (2012-2017) Figure India Overactive Bladder Therapeutics Sales (K Units) Market Share (%) by Type in 2017 Table India Overactive Bladder Therapeutics Sales (K Units) by Applications (2012-2017) Table India Overactive Bladder Therapeutics Sales (K Units) Market Share (%) by Applications (2012-2017) Figure India Overactive Bladder Therapeutics Sales (K Units) Market Share (%) by Applications in 2017 Figure Southeast Asia Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (2012-2017) Figure Southeast Asia Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (2012-2017) Figure Southeast Asia Overactive Bladder Therapeutics Price (USD/Unit) Trend (2012-2017) Table Southeast Asia Overactive Bladder Therapeutics Sales (K Units) by Players (2012-2017) Table Southeast Asia Overactive Bladder Therapeutics Sales (K Units) Market Share (%) by Players (2012-2017) Figure Southeast Asia Overactive Bladder Therapeutics Sales (K Units) Market Share (%) by Players in 2017 Table Southeast Asia Overactive Bladder Therapeutics Sales (K Units) by Type (2012-2017) Table Southeast Asia Overactive Bladder Therapeutics Sales (K Units) Market Share (%) by Type (2012-2017) Figure Southeast Asia Overactive Bladder Therapeutics Sales (K Units) Market Share (%) by Type in 2017 Table Southeast Asia Overactive Bladder Therapeutics Sales (K Units) by Applications (2012-2017) Table Southeast Asia Overactive Bladder Therapeutics Sales (K Units) Market Share (%) by Applications (2012-2017) Figure Southeast Asia Overactive Bladder Therapeutics Sales (K Units) Market Share (%) by Applications in 2017 Table Actavis Basic Information List Table Actavis Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Actavis Overactive Bladder Therapeutics Sales Growth Rate (2012-2017) Figure Actavis Overactive Bladder Therapeutics Sales Global Market Share (%) (2012-2017) Figure Actavis Overactive Bladder Therapeutics Revenue Global Market Share (%) (2012-2017) Table Allergan Basic Information List Table Allergan Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Allergan Overactive Bladder Therapeutics Sales Growth Rate (2012-2017) Figure Allergan Overactive Bladder Therapeutics Sales Global Market Share (%) (2012-2017) Figure Allergan Overactive Bladder Therapeutics Revenue Global Market Share (%) (2012-2017) Table Astellas Pharma Basic Information List Table Astellas Pharma Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Astellas Pharma Overactive Bladder Therapeutics Sales Growth Rate (2012-2017) Figure Astellas Pharma Overactive Bladder Therapeutics Sales Global Market Share (%) (2012-2017) Figure Astellas Pharma Overactive Bladder Therapeutics Revenue Global Market Share (%) (2012-2017) Table Pfizer Basic Information List Table Pfizer Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Pfizer Overactive Bladder Therapeutics Sales Growth Rate (2012-2017) Figure Pfizer Overactive Bladder Therapeutics Sales Global Market Share (%) (2012-2017) Figure Pfizer Overactive Bladder Therapeutics Revenue Global Market Share (%) (2012-2017) Table Addex Pharmaceuticals Ltd Basic Information List Table Addex Pharmaceuticals Ltd Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Addex Pharmaceuticals Ltd Overactive Bladder Therapeutics Sales Growth Rate (2012-2017) Figure Addex Pharmaceuticals Ltd Overactive Bladder Therapeutics Sales Global Market Share (%) (2012-2017) Figure Addex Pharmaceuticals Ltd Overactive Bladder Therapeutics Revenue Global Market Share (%) (2012-2017) Table Bayer Basic Information List Table Bayer Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Bayer Overactive Bladder Therapeutics Sales Growth Rate (2012-2017) Figure Bayer Overactive Bladder Therapeutics Sales Global Market Share (%) (2012-2017) Figure Bayer Overactive Bladder Therapeutics Revenue Global Market Share (%) (2012-2017) Table Elbion Basic Information List Table Elbion Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Elbion Overactive Bladder Therapeutics Sales Growth Rate (2012-2017) Figure Elbion Overactive Bladder Therapeutics Sales Global Market Share (%) (2012-2017) Figure Elbion Overactive Bladder Therapeutics Revenue Global Market Share (%) (2012-2017) Table Ipsen Basic Information List Table Ipsen Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Ipsen Overactive Bladder Therapeutics Sales Growth Rate (2012-2017) Figure Ipsen Overactive Bladder Therapeutics Sales Global Market Share (%) (2012-2017) Figure Ipsen Overactive Bladder Therapeutics Revenue Global Market Share (%) (2012-2017) Table Janssen Basic Information List Table Janssen Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Janssen Overactive Bladder Therapeutics Sales Growth Rate (2012-2017) Figure Janssen Overactive Bladder Therapeutics Sales Global Market Share (%) (2012-2017) Figure Janssen Overactive Bladder Therapeutics Revenue Global Market Share (%) (2012-2017) Table Kissei Pharma Basic Information List Table Kissei Pharma Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Kissei Pharma Overactive Bladder Therapeutics Sales Growth Rate (2012-2017) Figure Kissei Pharma Overactive Bladder Therapeutics Sales Global Market Share (%) (2012-2017) Figure Kissei Pharma Overactive Bladder Therapeutics Revenue Global Market Share (%) (2012-2017) Table Production Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Overactive Bladder Therapeutics Figure Manufacturing Process Analysis of Overactive Bladder Therapeutics Figure Overactive Bladder Therapeutics Industrial Chain Analysis Table Raw Materials Sources of Overactive Bladder Therapeutics Major Players in 2017 Table Major Buyers of Overactive Bladder Therapeutics Table Distributors/Traders List Figure Global Overactive Bladder Therapeutics Sales (K Units) and Growth Rate Forecast (2018-2023) Figure Global Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2023) Figure Global Overactive Bladder Therapeutics Price (USD/Unit) and Trend Forecast (2018-2023) Table Global Overactive Bladder Therapeutics Sales (K Units) Forecast by Regions (2018-2023) Figure Global Overactive Bladder Therapeutics Sales (K Units) Market Share (%) Forecast by Regions (2018-2023) Figure Global Overactive Bladder Therapeutics Sales (K Units) Market Share (%) Forecast by Regions in 2023 Table Global Overactive Bladder Therapeutics Revenue (Million USD) Forecast by Regions (2018-2023) Figure Global Overactive Bladder Therapeutics Revenue Market Share (%) Forecast by Regions (2018-2023) Figure Global Overactive Bladder Therapeutics Revenue Market Share (%) Forecast by Regions in 2023 Figure North America Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure North America Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2023) Figure Europe Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Europe Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2023) Figure China Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure China Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2023) Figure Japan Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Japan Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2023) Figure Southeast Asia Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Southeast Asia Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2023) Figure India Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure India Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2023) Table Global Overactive Bladder Therapeutics Sales Forecast by Type (2018-2023) Figure Global Overactive Bladder Therapeutics Sales Market Share (%) Forecast by Type (2018-2023) Table Global Overactive Bladder Therapeutics Revenue Forecast by Type (2018-2023) Figure Global Overactive Bladder Therapeutics Revenue Market Share (%) Forecast by Type (2018-2023) Table Global Overactive Bladder Therapeutics Price Forecast by Type (2018-2023) Table Global Overactive Bladder Therapeutics Sales Forecast by Application (2018-2023) Figure Global Overactive Bladder Therapeutics Sales Market Share (%) Forecast by Application (2018-2023) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Actavis Allergan Astellas Pharma Pfizer Addex Pharmaceuticals Ltd Bayer Elbion Ipsen Janssen Kissei Pharma